Soley Therapeutics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 39

Employees

  • Latest Deal Type
  • Series C

  • Latest Deal Amount
  • $200M

  • Investors
  • 9

Soley Therapeutics General Information

Description

Operator of a drug discovery platform intended to accelerate the development of therapies for complex diseases. The company offers an automated image-based technology using AI and machine learning to interpret cellular responses to compounds, enabling pharmaceutical and biotechnology researchers to identify drug candidates and improve decision-making across development programs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1 Corporate Drive
  • South San Francisco, CA 94080
  • United States
+1 (415)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 1 Corporate Drive
  • South San Francisco, CA 94080
  • United States
+1 (415)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Soley Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series C) 08-Jan-2026 $200M Completed Product Development
2. Early Stage VC (Series B) 15-Apr-2022 Completed Product Development
1. Early Stage VC (Series A) 18-Dec-2020 $20M $20M Completed Product Development
To view Soley Therapeutics’s complete valuation and funding history, request access »

Soley Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C
Series B
Series A 4,000,000 $0.001000 8% $5 $5 1x $5 13.22%
To view Soley Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Soley Therapeutics Patents

Soley Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026217529-A1 Celastrol combinations for the treatment of cancer Pending 08-Apr-2025
WO-2026213291-A1 Substituted heterocyclic modulators for the treatment of cancer Pending 02-Apr-2025
WO-2025255134-A1 Piperazinone based modulators for the treatment of disease Pending 04-Jun-2024
WO-2025255014-A1 Substituted heterocyclic modulators for the treatment of disease Pending 03-Jun-2024
EP-4695236-A1 Substituted phenyl-piperazinyl based modulators for the treatment of disease Inactive 14-Apr-2023 C07D401/12
To view Soley Therapeutics’s complete patent history, request access »

Soley Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Soley Therapeutics Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
HRTG Partners Fund of Funds Minority
Qudit Venture Capital Minority
RWN Management Family Office Minority
Surveyor Capital Hedge Fund Minority
Artisanal Ventures Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Soley Therapeutics FAQs

  • When was Soley Therapeutics founded?

    Soley Therapeutics was founded in 2020.

  • Where is Soley Therapeutics headquartered?

    Soley Therapeutics is headquartered in South San Francisco, CA.

  • What is the size of Soley Therapeutics?

    Soley Therapeutics has 39 total employees.

  • What industry is Soley Therapeutics in?

    Soley Therapeutics’s primary industry is Drug Discovery.

  • Is Soley Therapeutics a private or public company?

    Soley Therapeutics is a Private company.

  • What is the current valuation of Soley Therapeutics?

    The current valuation of Soley Therapeutics is .

  • What is Soley Therapeutics’s current revenue?

    The current revenue for Soley Therapeutics is .

  • How much funding has Soley Therapeutics raised over time?

    Soley Therapeutics has raised $290M.

  • Who are Soley Therapeutics’s investors?

    HRTG Partners, Qudit, RWN Management, Surveyor Capital, and Artisanal Ventures are 5 of 9 investors who have invested in Soley Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process